Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause
- 1 March 1995
- journal article
- clinical trial
- Published by Springer Nature in Clinical Rheumatology
- Vol. 14 (2) , 157-160
- https://doi.org/10.1007/bf02214935
Abstract
The effect of oestrogen replacement on bone metabolism and serum cytokine levels (IL1, IL6) was investigated in surgical menopause. The study included 40 female subjects; 10 healthy premenopausal women underwent total hysterectomy without oophorectomy. Thirty healthy premenopausal women underwent total hysterectomy with bilateral oophorectomy. They were randomly divided into 3 groups of 10 subjects. The first group received natural estradiol (0,05 mg/day) for 6 months; the second group received natural estradiol (0,05 mg/day) and medroxyprogesteron acetate (10 mg/day) for 6 months, the third group received no therapy. Calcium-phosphorus metabolism, inflammatory indices, serum IL1 and IL6 levels were tested before and 6 months after surgery in all patients. A significant increase in serum alkaline phosphatase, urinary cross-links, serum PTH and IL1-IL6 was observed in the untreated women with total hysterectomy and oophorectomy. No significant variation in any of the parameters considered was observed in patients treated with oestrogen, in those treated with oestrogens and medroxyprogesteron nor in patients without oophorectomy. These results in human “in vivo” confirm that ovarian steroids play an important role in regulating the production of IL1 and IL6 which could regulate bone resorption.Keywords
This publication has 12 references indexed in Scilit:
- Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: lack of regulation by 17 beta-estradiol.Endocrinology, 1992
- Perspectives: Interleukin-6: An osteotropic factor?Journal of Bone and Mineral Research, 1992
- 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.Journal of Clinical Investigation, 1992
- Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.Journal of Clinical Investigation, 1992
- Avian osteoclasts as estrogen target cells.Proceedings of the National Academy of Sciences, 1991
- Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells.Proceedings of the National Academy of Sciences, 1991
- Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotypeJournal of Bone and Mineral Research, 1991
- Evidence of Estrogen Receptors in Normal Human Osteoblast-Like CellsScience, 1988
- The Effect of Calcium-Regulating Hormones and Prostaglandins on Bone Resorption by Osteoclasts Disaggregated from Neonatal Rabbit Bones*Endocrinology, 1985
- Thyroid function and bone turnoverActa Endocrinologica, 1983